Quality Control (QC) in Clinical Research

Detail-oriented QC that delivers well-formatted, accurate, and consistent regulatory documents every time.

Thank you for the excellent QC, which gives us great comfort in the quality of the final document.
Medical Writing Director
Midsize Pharma Sponsor

QC services at MMS come complete with innovative, streamlined processes to ensure the creation of high-quality documents, delivered on-time with fewer drafts. This eases document development for Sponsor study teams and keeps their programs running at full-strength.

With fast and adaptive QC timelines, a global presence in multiple time zones, and a commitment to quality, you can expect the highest level of satisfaction for every project.

Accurate & Consistent QC Reviews

MMS provides QC as a service (QCAS) on documents we author, or as a stand-alone service. We employ a robust QC process that operates effectively or can be adapted to meet Sponsor-specific requirements. This design ensures the accuracy and consistency of data within any clinical or scientific document.

Additionally, we check documents against templates and style guides for proper formatting and style points. Using our proven method, we can QC any clinical, non-clinical, or scientific document quickly and efficiently. Our deep expertise in QCing medical writing deliverables expands across nearly all therapeutic areas.

The MMS QC Group has expertise in a broad range of regulatory documents, including:

  • Core documents, such as clinical study protocols, informed consent forms (ICF), clinical study reports (CSR), aggregate reports and common technical document (CTD) modules
  • Less common documents, such as briefing packages and responses to global health authority questions
  • Unique documents provided by Sponsors that need bespoke QC review
24-Hour Global QC Coverage

MMS is flexible across numerous times zones. With team members across India, South Africa, and the US, we can accommodate tight timelines and short notice. Our team meets daily to properly resource the best fit team member for each document type or therapeutic area.

We have the ability to train and grow new team members quickly to accommodate a growing number of requests.

Suggested For You

webinar

October 22nd, 2024

Optimal Strategies to Protect Commercially Confidential Information (CCI) in Clinical Documents and Report Trial Results Under Revised EU-CTIS Transparency Rules

perspectives

September 30th, 2024

Meet the Leaders Driving MMS’s European Growth

perspectives

September 30th, 2024

The Future of Data Management and Biostatistics: Trends and Technologies Shaping the Industry

perspectives

September 24th, 2024

Embracing Quality Management Maturity (QMM) at the Cornerstone of the Pharmaceutical Industry

perspectives

September 11th, 2024

From Historical Precedent to Modern Approvals: Lessons Learned on OTC Drug Products for FDA OMORs

webinar

September 26th, 2024

Regulatory Pathways for Nonprescription Drugs: A Deep Dive into OTC Monograph Reform and FDA Guidance

perspectives

September 4th, 2024

Email Security – Navigating Through the Process of Validation and Compliance with Healthcare Business Stakeholders

perspectives

August 27th, 2024

Optimizing Oncology Drug Development: FDA Expedited Pathways, Real-Time Review, and Global Programs

regulatory intelligence

August 27th, 2024

Recent Guidance on Diversity Action Planning

regulatory intelligence

August 26th, 2024

Oncology Programs at the FDA

regulatory intelligence

August 26th, 2024

Three Key Take Reflections on the Recent Donanemab Approval

perspectives

August 20th, 2024

Clinical Study Protocols: A Comprehensive Guide to Best Practices From A Senior Medical Writer